Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional

Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk

ClinicalTrials.gov ID: NCT00017134

Public ClinicalTrials.gov record NCT00017134. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 8:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Exploratory Evaluation of Fenretinide (4-HPR) as a Chemopreventive Agent for Ovarian Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known whether fenretinide given before surgery is more effective in preventing ovarian cancer than surgery alone. PURPOSE: Randomized clinical trial to compare the effectiveness of fenretinide followed by surgery with that of surgery alone in preventing ovarian cancer in patients who are at increased risk.

Study identification

NCT ID
NCT00017134
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
71 participants

Conditions and interventions

Conditions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2002
Primary completion
Nov 30, 2006
Completion
Not listed
Last update posted
Jun 9, 2013

Started 2002

United States locations

U.S. sites
35
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
Jonsson Comprehensive Cancer Center at UCLA Los Angeles California 90095-1781 —
Colorado Gynecologic Oncology Group P.C. Aurora Colorado 80010 —
Helen and Harry Gray Cancer Center at Hartford Hospital Hartford Connecticut 06102-5037 —
George Bray Cancer Center at New Britain General Hospital New Britain Connecticut 06050 —
Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale Florida 33308 —
Evanston Northwestern Healthcare - Evanston Hospital Evanston Illinois 60201-1781 —
St. Vincent Indianapolis Hospital Indianapolis Indiana 46260 —
Memorial Hospital of South Bend South Bend Indiana 46601 —
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242 —
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Kansas 66160-7357 —
Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington Kentucky 40536-0293 —
William Beaumont Hospital - Royal Oak Campus Royal Oak Michigan 48073 —
University of Minnesota Medical Center & Children's Hospital - Fairview Minneapolis Minnesota 55455 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65802 —
St. John's Regional Health Center Springfield Missouri 65804 —
Hulston Cancer Center at Cox Medical Center South Springfield Missouri 65807 —
Siteman Cancer Center at Barnes-Jewish Hospital St Louis Missouri 63110 —
CCOP - Northern New Jersey Hackensack New Jersey 07601 —
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
Mount Sinai Medical Center New York New York 10029 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina 28232-2861 —
McDowell Cancer Center at Akron General Medical Center Akron Ohio 44307 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267 —
Riverside Methodist Hospital Cancer Care Columbus Ohio 43214-3998 —
Mount Carmel Health - West Hospital Columbus Ohio 43222 —
Hillcrest Cancer Center at Hillcrest Hospital Mayfield Heights Ohio 44124 —
Oklahoma University Medical Center Oklahoma City Oklahoma 73104 —
Oregon Health & Science University Cancer Institute Portland Oregon 97239-3098 —
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown Pennsylvania 18105 —
University of Texas Medical Branch Galveston Texas 77555-0361 —
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401 —
Virginia Commonwealth University Massey Cancer Center Richmond Virginia 23298-0037 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00017134, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2013 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00017134 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →